Search

Your search keyword '"Papadopoulou, Charalampia"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Papadopoulou, Charalampia" Remove constraint Author: "Papadopoulou, Charalampia"
147 results on '"Papadopoulou, Charalampia"'

Search Results

3. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

4. The vasculopathy of Juvenile Dermatomyositis

7. OA36 Systemic juvenile idiopathic arthritis: the Great Ormond Street Hospital experience (2005-2021)

8. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)

9. INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry

12. Genetic testing of Behçet’s disease using next-generation sequencing to identify monogenic mimics and HLA-B*51

16. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

17. Efficacy and safety of emapalumab in macrophage activation syndrome

20. Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis

21. Efficacy and safety of emapalumab in macrophage activation syndrome

30. Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2

31. Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA): Treatment with Emapalumab, an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody

32. Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open‐Label, Randomized, Bayesian Noninferiority Trial

33. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study

37. Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)

42. ANALYSIS OF NEW REFERRALS TO A SPECIALIST UK ADULT AUTOINFLAMMATORY DISEASE SERVICE

44. Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With Neuroinflammation

46. FRI0537 LONG-TERM OUTCOMES AND TREATMENT EFFICACY IN PATIENTS WITH TNF RECEPTOR-ASSOCIATED AUTOINFLAMMATORY SYNDROME (TRAPS): A SERIES OF 290 CASES FROM THE EUROFEVER/EUROTRAPS INTERNATIONAL REGISTRY

49. Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models.

50. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.

Catalog

Books, media, physical & digital resources